OncBioMune Pharmaceuticals, Inc. announced that Brian Barnett, MD, has been appointed as Chief Executive Officer effective December 26, 2018. Dr. Barnett replaces Dr. Jonathan Head in this position. Dr. Head will continue to serve the Company as the Chairman of the Board of Directors and now as its Chief Scientific Officer effective December 26, 2018.

Prior to joining the Company, Dr. Barnett served at Puma Biotechnology, Inc. since August 2016 (“Puma”) most recently as a Vice President and Head of Medical Affairs. Prior to his time with Puma, Dr. Barnett was with Genentech, Inc. from October 2012 to August 2016 and served most recently as the Medical Director, Kadcyla (T-DM1), Global Product Development Oncology. Prior to his appointment as CEO, Dr. Barnett was a member of Scientific Advisory Board.

Dr. Barnett received his B.S. from Millsaps College and M.D. from the University of Mississippi.